Enzymotec Ltd. (NASDAQ:ENZY) reported 6/30/2017 earnings this Morning, coming in at ($0.10) per share, missing Wall Street’s estimates of $0.05 per Share. Revenue for the quarter came in at $13.00 million beating analyst estimates of $12.78 million
Analyst Coverage For Enzymotec Ltd. (NASDAQ:ENZY)
These are 2 Hold Ratings .
The current consensus rating for Enzymotec Ltd. (NASDAQ:ENZY) is Hold (Score: 2.00) with a consensus target price of $8.00 , a potential (22.33% downside)
Recent Trading for Enzymotec Ltd. (NASDAQ:ENZY) Shares of Enzymotec Ltd. closed the previous trading session at 10.25 down -0.15 -1.44% with 19,550 shares trading hands.